Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

ANVS

Annovis Bio (ANVS)

Annovis Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:ANVS
일자시간출처헤드라인심볼기업
2024/05/1405:05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
2024/05/1320:30GlobeNewswire Inc.Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial ResultsNYSE:ANVSAnnovis Bio Inc
2024/05/1106:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ANVSAnnovis Bio Inc
2024/05/1005:03Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
2024/05/0920:30GlobeNewswire Inc.Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s DiseaseNYSE:ANVSAnnovis Bio Inc
2024/05/0706:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:ANVSAnnovis Bio Inc
2024/05/0706:11Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
2024/05/0620:30GlobeNewswire Inc.Annovis Bio CEO Maria Maccecchini Issues Letter to StockholdersNYSE:ANVSAnnovis Bio Inc
2024/04/2923:10GlobeNewswire Inc.Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s DiseaseNYSE:ANVSAnnovis Bio Inc
2024/04/0220:30GlobeNewswire Inc.Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial ResultsNYSE:ANVSAnnovis Bio Inc
2024/02/2821:08IH Market NewsUS Stock Movers Before Market: Beyond Meat, eBay, First Solar, Urban Outfitters…NYSE:ANVSAnnovis Bio Inc
2024/02/1304:00Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NYSE:ANVSAnnovis Bio Inc
2024/02/0206:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NYSE:ANVSAnnovis Bio Inc
2023/11/2306:27Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
2023/11/2306:24Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
2023/11/2306:21Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
2023/11/2306:14Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
2023/11/2204:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
2023/11/2204:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
2023/11/2204:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
2023/11/2204:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
2023/11/0906:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ANVSAnnovis Bio Inc
2023/11/0220:30Business WireAnnovis Bio Measures Novel Biomarkers in Plasma of Parkinson’s PatientsNYSE:ANVSAnnovis Bio Inc
2023/11/0201:28Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
2023/11/0201:24Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ANVSAnnovis Bio Inc
2023/10/3121:00Business WireAnnovis Bio Announces Pricing of $7.5 Million Public OfferingNYSE:ANVSAnnovis Bio Inc
2023/10/3106:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ANVSAnnovis Bio Inc
2023/10/3106:17Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
2023/10/3105:48Business WireAnnovis Bio Announces Launch of Proposed Public OfferingNYSE:ANVSAnnovis Bio Inc
2023/10/3105:42Business WireAnnovis Bio Receives Positive Recommendation to Continue Phase 2/3 Trial of Buntanetap for Alzheimer’s Disease Patients From the Independent Data and Safety Monitoring Board (DSMB)NYSE:ANVSAnnovis Bio Inc
 검색 관련기사 보기:NYSE:ANVS